Category: <span>Dr. Richard Pazdur</span>

Category: Dr. Richard Pazdur

Dako North America Inc., Dr. Richard Pazdur, Dr. Roger M. Perlmutter, FDA, Immunotherapy, Keytruda, Merck, mesothelioma cancer, Mesothelioma News, Non-small cell lung cancer, NSCLC, PD-L1, U.S. Food and Drug Administration

FDA-Approved Keytruda Treatment Could Help Mesothelioma Patients

 

Recently, the FDA approved Merck immunotherapy drug Keytruda for treatment in non-small cell lung cancer and is bringing hope to mesothelioma patients.

Amgen, Antonio Chiocca, Brigham and Women's Hospital, Checkpoint inhibitors, Dr. Richard Pazdur, Dr. Tim Turnham, Howard Kaufman, Imlygic, John Bell, Mesothelioma News, Oncolytics Biotech, Ottawa Hospital Research Institute, Rutgers Cancer Institute, Stage three melanoma, US Food and Drug Administration

New FDA-Approved Cancer-Killing Virus Is Released

 

A new cancer-killing virus has been approved by the FDA that could pave the way for future cancer treatments.

Bristol-Myers Squibb, Dr. Richard Pazdur, Dr. Roy Herbst, Dr. Scott Gettinger, FDA, Immunotherapy, Keytruda, Merck, mesothelioma, Mesothelioma News, Mesothelioma treatment, Opdivo

Can Opdivo Drug Be Good News for Mesothelioma Patients?

 

Expanded approved use of new lung cancer drug Opdivo could give malignant pleural mesothelioma patients hope.